Corient Private Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Corient Private Wealth's LLY Position: Q2 2026 in Review
Corient Private Wealth reduced its Eli Lilly (LLY) stake by 9.5% in Q2 2026, selling an estimated $63.5M and leaving 592,599 shares worth $711M. The position accounts for 0.98% of the portfolio, ranked #14.
Corient Private Wealth first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $737M in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Corient Private Wealth held 592,599 shares of Eli Lilly worth $711M as of Q2 2026.
- Corient Private Wealth sold 62,188 Eli Lilly shares in Q2 2026, an estimated $63.5M.
- Eli Lilly made up 0.98% of Corient Private Wealth's portfolio in Q2 2026, its #14 holding.
- Corient Private Wealth first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- Corient Private Wealth's Eli Lilly position peaked at $737M in Q4 2025.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.